The Latest Breaking News from Vaccine

The rising cases are placing further pressure on Canberra's health system.

After virtually disappearing for two years, influenza is back and rapidly sweeping across Australia – and the world.

More than 220 million unique health ids have already been issued, he says

New York-based pharmaceutical firm SIGA Technologies (NASDAQ: SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox.

Graham was a healthy 34-year-old until he developed COVID in July 2020. Along with his wife and children, he had a fever, a cough, breathlessness, profound fatigue and he lost his sense of smell.

Dame Sarah Gilbert and Dr Catherine Green helped create the Oxford, AstraZeneca vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours.

Poor messaging around booster shots has left millions at risk, researchers say

With cases of monkeypox inexplicably on the rise outside of Africa - where the viral disease is endemic - public health officials are using contact tracing, isolation and targeted vaccination to curb its spread.

Some countries do not allow entry without proof of full vaccination, while others operate strict testing regimes

Pfizer Inc (NYSE:PFE) will sell over 20 patent-protected drugs and vaccines at not-for-profit prices to 45 of the world's poorest countries. Under the program, Pfizer will begin shipping the medicines first to Ghana, Malawi, Rwanda, Senegal, and Uganda before the end of this year, Chief Executive Albert Bourla said in an interview. This will…